Single-chain recombinant clotting factor VIII (lonoctocog alfa): clinical experience in Russia
Despite significant progress in haemophilia treatment, achieved in Russia recently, number of unmet medical needs still exist in routine clinical practice. Particularly, the annual bleeding rates are still high, leading to frequent development of synovitis and haemophilic arthropathy, resulting in c...
Saved in:
Main Author: | M. V. Kosinova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Open Systems Publication
2022-02-01
|
Series: | Лечащий Врач |
Subjects: | |
Online Access: | https://journal.lvrach.ru/jour/article/view/886 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Acquired Hemophilia A Associated with NSAID: A Case Report
by: Diane Lukito Setiawan, et al.
Published: (2019-11-01) -
Acquired Hemophilia A Associated with NSAID: A Case Report
by: Diane Lukito Setiawan, et al.
Published: (2019-11-01) -
Altuvoct: Innovative Medicinal Products Benefit from Innovative Approaches to Regulatory Assessment
by: Essam Kerwash, et al.
Published: (2025-05-01) -
Factor VIII products: key aspects of development, clinical research and use (part 2)
by: Zh. I. Avdeeva, et al.
Published: (2021-07-01) -
Clinical profile and outcome of children with haemophilia A: The Royal Hospital, Oman’s experience
by: AlRawahi Anood, et al.
Published: (2025-03-01)